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ABSTRACT 
In this paper a novel stimuli responsive hydrogel material, methacrylated 
sodium alginate beta-cyclodextrin (Alg-MA-β-CD), was used in combination with a 
microfluidic device to create microspheres. Currently there is no reliable method for 
fabricating homogeneous stimuli-responsive microspheres, in-house microfluidic devices 
are not reliable in manufacture quality or long-term use. Alginate hydrogels have many 
attractive characteristics for bioengineering applications and are commonly used to 
mimic the features and properties of the extracellular matrix (ECM). Human 
mesenchymal stem cells (hMSCs) are of top interest to tissue engineers. hMSCs are 
widely available and can be harvested and cultured directly out of human bone marrow.  
hMSCs have the ability to differentiate into osteoblasts, adipocytes, chondrocytes, muscle 
cells, and stromal fibroblasts depending on mechanical signals transmitted through 
surrounding ECM. The biomechanical properties of alginate based stimuli-responsive 
hydrogels can be tuned to match those of different types of tissues. When trying to 
transport and control the differentiation of hMSCs into generating new tissues or 
regenerating damaged tissues, it is highly beneficial to encapsulate the cells inside a 
microsphere made from these hydrogels.    The proposed research objectives are: 1) To 
optimize fabrication techniques and create functional microfluidic devices; 2) Analyze 
the effects of flow parameters on microsphere production; and 3) Encapsulate viable 
hMSCs inside multi-stimuli responsive alginate microspheres using the fabricated 
microfluidic devices (MFDs). In this study, photolithography microfabrication methods 
were used to create flow-focusing style MFDs. The hydrogel materials were 
characterized via rheological methods. Syringe pumps controlled flow rates of fluids 
through the devices. Active droplets formation was monitored through a camera attached 
to an inverted microscope, where images were analyzed. Microsphere production was 
analyzed optically and characterized. Alg-MA-β-CD polymer solutions containing 
hMSCs were encapsulated, and a live/dead florescence assay was preformed to verify cell 
viability.  Using a modified fabrication process it was possible to manufacture Alg-MA-
β-CD microspheres and encapsulate and maintain viable hMSCs inside. 
 
 
 
  
ii 
 
 
ACKNOWLEDGEMENTS  
I would like to acknowledge my loving mother Cindy Karasinski for supporting any 
direction of my life. Also my blood brother Jared Karasinski, who’s advice is 
always valuable. Also John Vetter and Topher Waring for encouraging me to 
pursue college’s finest certificates.  
I would also like to thank Rachael Oldinski for volunteering to be my advisor and 
offering her guidance and expertise on the academic front. 
Also special thanks to Jennifer Etter for bravely putting up with me for two years of 
graduate school. Without her friendship, I would not have made it out of here.  
My assistant and friend, Lord Jesse Ware IV, deserves an honorable mention for his 
time devoted to bioengineering research.  
I thank John Karasinski, my father, the greatest man I will ever know, for the gift of 
life and its glorious opportunities.  I wish he could have been here to see this 
through. 
  
iii 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ............................................................................................. ii 
LIST OF TABLES .......................................................................................................... vi 
LIST OF FIGURES ....................................................................................................... vii 
CHAPTER 1: BACKGROUND AND SUMMARY....................................................... 1 
1.1. Alginate and Chemical Functionalization ........................................................... 1 
1.2. Alginate Hydrogels and Microspheres for Biomedical Applications ................. 7 
1.3. Microfluidics.......................................................................................................... 9 
1.4. Photolithography Techniques ................................................................................ 9 
1.5. Thesis Objectives ................................................................................................. 12 
Objective 1 ................................................................................................................ 12 
Objective 2 ................................................................................................................ 12 
Objective 3 ................................................................................................................ 13 
CHAPTER 2: FRABRICATING THE MICROFLUIDIC FLOW FOCUSING 
DEVICE ......................................................................................................................... 14 
2.1. Introduction.......................................................................................................... 14 
2.2. Materials and Methods ........................................................................................ 14 
2.2.1. Photolithography Methods .............................................................................. 14 
2.2.2. PDMS Mold .................................................................................................... 17 
  
iv 
 
2.2.3. Corona Bonding Treatment ............................................................................ 18 
2.3. Results and Discussion ........................................................................................ 20 
CHAPTER 3: EFFECT OF FLOW PARAMETERS IN MFD ..................................... 25 
3.1. Microfluidic Theory............................................................................................. 25 
3.2. Materials and Methods ........................................................................................ 27 
3.3. Results and Discussion ........................................................................................ 32 
CHAPTER 4: CELL ENCAPSULATION .................................................................... 46 
4.1. Introduction.......................................................................................................... 46 
4.1.1. Live/Dead Assay for Cell Encapsulation ........................................................ 47 
4.2. Materials and Methods ........................................................................................ 49 
4.3. Results and Discussion ........................................................................................ 52 
CHAPTER 5: CONCLUSIONS AND FUTURE WORK ............................................. 58 
5.1. Objective Conclusions ......................................................................................... 58 
Objective 1 Conclusions ........................................................................................... 58 
Objective 2 Conclusions ........................................................................................... 58 
Objective 3 Conclusions ........................................................................................... 59 
5.3. Future Work Recommendations .......................................................................... 60 
REFERENCES .............................................................................................................. 61 
APPENDICES ............................................................................................................... 65 
  
v 
 
Manuals/Protocols ......................................................................................................... 65 
Standard Operating Procedure: Production of a MFD Using Soft 
Photolithography ....................................................................................................... 65 
Standard Operating Procedure: Rheo-Visco-Alg-MA-β-CD-Testing ...................... 69 
Standard Operating Procedure: MFDs-Cell-Encapsulation-Alg-MA-β-CD-
GreenLight ................................................................................................................ 75 
Abstracts ........................................................................................................................ 78 
Manufactured Alginate Drug Delivery Vehicles for Disease Prevention and 
Tissue Regeneration .................................................................................................. 78 
Society of Biomaterials Spring 2017: Manufacturing Methacrylated Sodium 
Alginate Beta-Cyclodextrin Microspheres for Drug Delivery ................................. 81 
Rheological Data............................................................................................................ 82 
 
 
 
  
vi 
 
LIST OF TABLES  
Table 1: Recommendations for SU-8 2075 conditions for varying thicknesses during 
photolithography are shown below. .................................................................................. 20 
Table 2: Showing six different chip junctions, measured at orifices in µm. Chips 1-5 
are fabricated with a 30µm photomask, chip 6 is fabricated with an 8µm photomask 
as a comparision. The letters a,b,c,d represent the diameter of orifices at the junction 
where channels;  alginate inlet, mineral oil left, mineral oil right, and emulsion exit, 
respectfully meet. .............................................................................................................. 24 
Table 3: Varying Flow Parameters and Observing Droplet Size ...................................... 42 
Table 4: Varying Flow Parameters and Observing Droplet Size of Device 2. ................. 43 
  
vii 
 
LIST OF FIGURES  
Figure 1: Chemical structure of alginate with hydroxyl (blue solid circles) and 
carboxyl groups (purple dashed circles) [7]........................................................................ 2 
Figure 2: Calcium Ion Crosslinking of Sodium Alginate to with Four G Monomers 
Forming an “Egg-Box” [14] ............................................................................................... 4 
Figure 3: Chemical Structure of β-Cyclodextrin [20] ......................................................... 6 
Figure 4: A general photolithograph process, from masking phase to PDMS bonding 
[40]. ................................................................................................................................... 16 
Figure 5: SU-8 bonding to glass with different cleaning methods. Left: water wash 
with glass cleaner. Middle: Water wash with glass cleaner and a 30min 200C°. 
Right: Acetone wash. ........................................................................................................ 22 
Figure 6: Diagram of junction orifices to support Table 2. .............................................. 23 
Figure 7: The dispersion fluid, 2% alginate solution, is shown in green, the 
continuous fluid, mineral oil, is shown in yellow. The green dot is the alginate inlet, 
the yellow dot is the mineral oil inlet, and the blue dot is the emulsion exit. ................... 27 
Figure 8: Chemical drawings depicting the modification of alginate to Alg-MA and 
again to Alg-MA-β-CD. Also the β-Cyclodextrin structure is shown with its 
simplified conic shape....................................................................................................... 30 
Figure 9: Mineral oil with and without 2% Span80 at 25°C and 37°. This shows that 
adding the surfactant doesn’t change the viscous behavior. ............................................. 33 
Figure 10: 2% Alginate solution average viscosities at 25°C and 37°C showing a 
slight temperature dependence. ......................................................................................... 34 
Figure 11: Left: 2% Na-Alg Microspheres after calcium chloride bath crosslinking. 
Right: SEM after washing and lyophilizing...................................................................... 35 
Figure 12: 2% Alginate solution with 2% F108 is shown with average viscosities at 
25°C and 37°C. ................................................................................................................. 36 
Figure 13: 2% Alginate solutions with and without 2% F108 are tested at varying 
shear rates and  viscosities at 25°C and 37°C are recorded. ............................................. 37 
  
viii 
 
Figure 14: Average 2% alginate solutions with calcium chloride introduced at 1 
minute.  Crosslinking can be observed as G’ dominates G”............................................. 38 
Figure 15: The red points show the Alg-MA-β-CD with a 1:1ration of F108. The 
crosslinking happens at around 27C°. Notice the control, without F108, also has 
elastic properties dominating a around 33C°, this can be attributed to dehydration of 
the maerial. ........................................................................................................................ 39 
Figure 16: Effects of Changing Concentration of Triethanolamine (TEOA) in 2% 
Alg-MA-β-CD on Crosslinking Time ............................................................................... 40 
Figure 17: Photos of the Junctions of MFDs used in Table 2 ........................................... 41 
Figure 18: Photos of MFD Drop Generation for Device 2 at Varying Flow Rates .......... 44 
Figure 19:  Hydrogel as a Cell Scaffold [21] .................................................................... 47 
Figure 20: Live/Dead assay fluorescence. Component A is green, Calcein AM, and 
component B is red, ethidium homodimer-1. The green dye stains all cells; the red 
dye stains only dead cells, but fluoresces forty times brighter than the green. ................. 49 
Figure 21: A visualization of the experimental set up used to encapsulate hMSCs 
inside a MFD using 2% Alg-MA-β-CD and green light and calcium chloride 
crosslinking. ...................................................................................................................... 51 
Figure 22: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~1 hour after the cells were added to the Alg-MA--CD and crosslinked in 
1M calcium chloride a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube 
d.) Magnified image of dead (red fluorescent) encapsulated cell ..................................... 53 
Figure 23: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~2 hours after the cells were added to the Alg-MA--CD and failed to 
crosslink into microspheres under intermittent green light, but still proved cells could 
survive the process and remain at room temperature for 2 hours in the Alg-MA--CD 
material. a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube d.) 
Magnified Green/Red Overlay of Bright Field ................................................................. 54 
  
ix 
 
Figure 24: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~4 hours after the cells were added to the Alg-MA--CD and failed to 
crosslink into microspheres and it was discovered that the mineral oil with 2% 
Span80 has a red fluorescence from either the material properties or uptakes the 
live/dead stain used. A.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube 
d.) Magnified Green/Red Overlay of Bright Field............................................................ 55 
Figure 25: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained 12 hours after the cells were added to the Alg-MA--CD and crosslink into 
microspheres under constant green light and in a 0.4M calcium chloride and cell 
media bath. a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube d.) 
Magnified Green/Red Overlay of Bright Field ................................................................. 56 
Figure 26: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~13 hours after the cells were added to the Alg-MA--CD and crosslink 
into microspheres under constant green light and in a 0.01M calcium chloride and 
cell media bath a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube d.) 
Magnified Green/Red Overlay of Bright Field ................................................................. 57 
Figure 27: Mineral Oil Viscosity Test at 25°C ................................................................. 82 
Figure 28: Mineral Oil Viscosity Test at 37°C ................................................................. 83 
Figure 29: Comparison of Average of Mineral Oil at 25°C and 37°C ............................. 84 
Figure 30: Mineral Oil with 2% Span80 Viscosity at 25°C ............................................. 85 
Figure 31: Mineral Oil with 2% Span80 Viscosity at 37°C ............................................. 86 
Figure 32: Mineral Oil with 2% Span80 Average Viscosities at 25°C and 37°C ............ 87 
Figure 33: 2% Alg Viscosity at 25°C ............................................................................... 88 
Figure 34: 2% Alg Viscosity at 37°C ............................................................................... 89 
Figure 35: 2% Alg Average Viscosities at 25°C and 37°C .............................................. 90 
  
x 
 
Figure 36: 2% Alg-MA Viscosity at 25°C ........................................................................ 91 
Figure 37: 2% Alg-MA Viscosity at 37°C ........................................................................ 92 
Figure 38: 2% Alg-MA Average Viscosities at 25°C and 37°C....................................... 93 
Figure 39: 2% Alg-MA-β-CD Viscosity at 25°C ............................................................. 94 
Figure 40: 2% Alg-MA-β-CD Viscosity at 37°C ............................................................. 95 
Figure 41: 2% Alg-MA-β-CD Average Viscosities at 25°C and 37°C ............................ 96 
Figure 42: 2% Alg and 2% F108 Viscosity at 25°C ......................................................... 97 
Figure 43: 2% Alg and 2% F108 Viscosity at 37°C ......................................................... 98 
Figure 44: 2% Alg and 2% F108 Averages Viscosity at 25°C 37°C ................................ 99 
Figure 45: 2% Alg-MA and 2% F108 Viscosity at 25°C ............................................... 100 
Figure 46: 2% Alg-MA and 2% F108 Viscosity at 37°C ............................................... 101 
Figure 47 : 2% Alg-MA and 2% F108 Average Viscosities at 25°C and 37°C ............. 102 
Figure 48: 2% Alg-MA-β-CD and 2% F108 Viscosity at 25°C ..................................... 103 
Figure 49: 2% Alg-MA-β-CD and 2% F108 Viscosity at 37°C ..................................... 104 
Figure 50: 2% Alg-MA-β-CD  and 2% F108 Average Viscosities at 25°C and 37°C ... 105 
Figure 51: 2% Alg Time Sweep with 1M calcium chloride Added at 1 Minute ............ 106 
Figure 52: 2% Alg-MA Time Sweep with 1M calcium chloride Added at 1 Minute .... 107 
Figure 53: 2% Alg-MA-β-CD  Time Sweep with 1M calcium chloride Added at 1 
Minute ............................................................................................................................. 108 
Figure 54: 2% Alg-MA-β-CD  and 2% F108 Time Sweep with 1M calcium chloride 
Added at 1 Minute .......................................................................................................... 109 
  
1 
 
 CHAPTER 1: BACKGROUND AND SUMMARY 
1.1. Alginate and Chemical Functionalization 
Alginate is a natural derived polysaccharide extracted from the cell wall of the 
brown algae Laminaria digitate. chemical composition varies with species, season, 
location, and extraction process [1-3].  Alginate is extracted from the plant matrix in 
many ways. Commonly the leaves are sliced, diced, and washed with hot water and 
sodium carbonate. Alginate from within the seaweed then bonds with sodium, and 
dissolves in water. The remaining plant cellulose is removed in various extraction 
processes and the sodium alginate is dehydrated and ground to desired sizes [1].  Alginate 
ranges in molecular weight from 500 to 1,000 kDa [3]. The solubility of the alginate 
polymer is dependent on the polymer concentration, solution pH, and ions present in the 
solution[3]. Outside of textile, cosmetic, pharmaceutical or biomedical industries, 
alginate is commonly found in food as a thickening agent [2, 4].  
At the molecular level, alginate is a binary copolymer and consists of (1-4) 
linked β-D-mannuronic acid (M) and α-L-guluronic acid (G) monomers [2].  Alginate can 
either have heteropolymeric segments with GM or MG monomers or homopolymeric 
segments with GG or MM monomers [3]. An example of a sequence of the GG/MM 
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block structure can be seen in 
 
 
Figure 1 [2]. The monomer sequence of the G and M monomers can differ between 
different locations of the same piece of seaweed [5]. Alginate has a large number of 
unused carboxyl and hydroxyl groups, which allow for easy functionalization via 
chemical reactions. Altering these groups can alter the chemical and mechanical behavior 
of the alginate [6].   
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Figure 1: Chemical structure of alginate with hydroxyl (blue solid circles) and 
carboxyl groups (purple dashed circles) [7] 
Alginate in solution can be crosslinked to form a hydrogel in the presence of 
divalent or multivalent cations including calcium (Ca2+), strontium  (Sr2+), and barium 
(Ba2+) [8]. The crosslinking occurs when the calcium ion bonds to the hydroxyl and 
carboxylate groups of four G monomers of two nearby polymer chains. The four G 
monomers form a shape that is referred to as the “egg box’ model [8].  The crosslinking 
of alginate with calcium ions can be seen below in Figure 2. Composition and 
crosslinking method can be controlled to determine hydrogel properties. Its well known 
that sodium alginate in solution will crosslink with calcium ions.   
The alginate can be changed to allow for other avenues of crosslinking, such as 
with light exposure. The alginate is modified to become Methacrylated Alginate (Alg-
MA) by adding Methacyrlic anhydride; the chemical structure can be seen in Figure .  
Alg-MA is synthesized by the esterification of the hydroxyl groups found on the 
polysaccharide alginate with methacrylic anhydride [9]. The acrylate functional group is 
able to covalently crosslink to other acrylate functional groups by free radical 
polymerization when a photo-initiator is added [10-12]. It is also possible to use a 
photosensitizer with methacrylated alginate in order to allow the use of visible green light 
rather than UV light [11-13].  In order to covalently crosslink the Alg-MA with visible 
green light Eosin Y, triethanolamine, and 1-vinyl-2-pyrrolidinone can be used as the 
photo-sensitizer, photo-initiator, and catalyst respectfully [11].  
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Figure 2: Calcium Ion Crosslinking of Sodium Alginate to with Four G Monomers 
Forming an “Egg-Box” [14] 
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Figure 3: Chemical Structure of Methacyrlic Anhydride [15]  
 
Further material control can be obtained by adding β-cyclodextrin groups to 
alginate. Cyclodextrins can be attached to alginate at the carboxyl group [16].  The 
cyclodextrin groups are cyclic oligosaccharides that are composed usually 6, 7 or 8 D-
glucopyranose units [17, 18]. The cyclodextrins are linked into a cyclic shape by α-1,4-
glucosidic bonds [17].  This specific bond formation allows the cyclodextrin molecule to 
form ‘cups’ with hydrophobic interior cavities and hydrophilic exterior surfaces. 
Cyclodextrins can be attached to alginate at the carboxyl group [16]. The chemical 
structure of the cyclodextrin used in this experiment (β-cyclodextrin) can be seen in 
Figure 3. This specific bond formation allows for the cyclodextrin molecule to form 
‘cups’ with hydrophobic interior cavities and hydrophilic exterior surfaces. The 
hydrophobic nature of the interior cavities of these ‘cups’ allow for the inclusion of many 
different types of guest molecules and polymers and remain in place via non-covalent 
interactions [19]. 
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Figure 3: Chemical Structure of β-Cyclodextrin [20] 
This specific bond formation allows for the cyclodextrin molecule to form 
‘cups’ with hydrophobic interior cavities and hydrophilic exterior surfaces. The 
hydrophobic nature of the interior cavities of these ‘cups’ allow for the inclusion of many 
different types of guest molecules and polymers and remain in place via non-covalent 
interactions [19]. A schematic of the 3 types of ‘cups’ formed by different types of 
cyclodextrins can be seen in Figure 3.  
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1.2. Alginate Hydrogels and Microspheres for Biomedical Applications  
Alginate is commonly used in tissue engineering applications because of its 
extensive properties. Due to the hydrophilic characteristics, alginate can be dissolved in 
water-based solutions such as cell media, and phosphate buffer solution (PBS).  
Alginate hydrogels are used to control the structure and function relationship of 
engineered tissues as well as to carry and maintain viable cells to tissue regeneration sites 
[21]. Alginate allows for nutrient and oxygen delivery to encapsulated cells. Alginate can 
be modified to promote cell adhesion and growth inside of a microsphere [22]. The 
material properties can be controlled to stimulate stem cell differentiation [23]. This may 
make it possible to regrow different complex tissues including bone, nerves, and cartilage 
[24].  
Alginate hydrogels are also being extensively studied for drug delivery 
applications. The hydrogel can crosslink and capture chemical molecules within their 
hydrogel matrix [10]. Material density and crosslinking method affect matrix pore size 
and solute diffusion rates depending on radius of gyration [25]. Different types of 
crosslinking can occur to help control the resistance to breakdown and dispersion. For 
example, a simple calcium crosslinked alginate hydrogel will break down in water in a 
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few days, but by adding photo initiators and crosslinking with light, the hydrogel can 
maintain structure much longer [26].  
The biomedical field has also taken large interests in developing and applying 
alginate microspheres. Currently there exists a number of methods for creating 
microsphere, for many materials including alginate species. Microspheres are 
manufactured with other techniques, such as mixing emulsions on stir plates at high 
speeds forming colloids or from the fine particles sprayed from atomizers. The resulting 
microspheres are not homogenous in size. There exist methods to filter or sieve the mixed 
solutions of spheres, resulting in wasted material and time [27] .  Ideally, there is a way to 
create microspheres at the required size, which may be possible with the use of a MFD. 
Alginate microspheres can be made with multilayers and carry different types of payloads 
into the body. Each layer can have a different protein, or combination, to act in a 
signaling sequence. Alginate microspheres are ideal for tuning drug release 
specifications, even between different patients [28]. Also with injectable hydrogel 
microspheres, it is possible to treat localized areas of the body, which is especially 
beneficial for harmful therapeutics.  In addition, the microsphere size can be controlled 
depending on the target; sometimes it may be beneficial to deliver a chemical 
intracellularly, which can be done my making the microspheres very small, around the 1 
micron size [29]. 
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1.3. Microfluidics 
Microfluidics is an expanding field due to precise control capabilities afforded 
by using small controlled portions of material. Microfluidic flow focusing devices 
(MFDs) allow multiple experiments to be performed on small scales with accurate 
metering capability.  The field of microfluidics applies directly to chemical synthesis, 
biological analysis, optics, and information technology [30]. Microfluidic flows typically 
exhibit the properties of low Reynolds numbers and high surface tension [31]. When 
dissimilar and immiscible fluids meet at a designed junction, the dispersion phase fluid 
extends until a droplet breaks off due to Rayleigh instability [32]. A narrowing section of 
the junction creates a point of high shear. The continuous phase fluid extends and pinches 
off the dispersion phase fluid forming uniform droplets. The sizes of the droplets 
decrease by increasing the flow rate of the continuous phase. Alternatively, an increase in 
dispersion phase flowrate also increases the frequency of droplet generation [33]. 
Polydimethylsiloxane (PDMS) is a silicone based organic polymer that has desirable 
properties for micro channel creation. PDMS is inexpensive, rapidly produces prototypes, 
and is biocompatible, allowing the MFDs made of it to be economic and safe [34]. 
 
1.4. Photolithography Techniques  
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Photolithography (lithography) is a microfabrication process in which a polymer 
sensitive to light is exposed in a pattern that can be developed to reveal a three 
dimensional relief on a substrate. In theory, after exposure and development, the polymer 
is only and exactly present in desired locations. Locations, designs, and areas are shielded 
from exposure by a covering known as a photomask.  However, it is well known that this 
technique does not always produce features with the desired size due to the sensitivity of 
working at such a small scale [34].  
Photolithography is a method commonly used to create printed circuit boards. A 
mask containing a circuit design is exposed to light passing the projected image of the 
design onto a substrate. Modern geometries require tolerances on the nanometer scale, 
and short wavelengths of pure UV light allow for this afforded precision. It is not hard to 
imagine the extension of this principle to the creation of a microfluidic device. A 
microfluidic channel is just like a microcircuit, with the respect that it is a micro-sized 
three-dimensional feature. Instead of ending with lands of conductive material, the 
process of fabricating a microfluidic device leaves hollow channel geometries for fluids 
to flow through [35]. 
SU-8 is a UV light sensitive polymer, sometimes called a photoresist. SU-8 has 
a negative tone, meaning that the exposure to UV light crosslinks the polymer, making it 
insoluble, leaving unexposed portions the ability to dissolve in a photoresist developing 
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solution. Conversely, a photoresist with a positive tone will only dissolve once it is 
exposed [35]. 
 In general, the photolithography method follows this sequence: 
1. The substrate material cleaning of contaminants such as dust, oils, and absorbed 
water.   
2. The deposition of a thin layer of photoresist material on top of the substrate using 
various methods such as spin coating or vacuum vapor deposition.  
3. A pre-exposure bake to ensure that the contact of a photomask does not disturb 
the photoresist.  
4. Photomask positioning and exposure of light source.  
5. A post-exposure bake phase cures the cross-linked photoresist material.  
6. Development involves washing away undesired three-dimensional portions.  
7. Some processes require a wash to remove the developing solution, depending on 
the type of photoresist; isopropyl alcohol is a common wash.   
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1.5. Thesis Objectives 
Objective 1 
To optimize fabrication techniques and create functional (MFDs). The first objective 
will be focused on creating a MFD that will reliably function, and stay in use for 
extended time durations. MFDs need to have their layers bonded with sufficient strength 
to avoid delamination from internal fluid pressures. These MFDs will reproducibly 
generate monodisperse alginate microspheres. The photolithography methods that are 
used to create a mold from, which the MFD is fabricated, will be examined and modified 
to achieve this objective. 
Objective 2 
To analyze the effects of flow parameters on microsphere production.  Once 
functional MFDs are created, this study will look to examine how changing the inlet flow 
parameters, effects the output microsphere size for different alginate materials.  Expected 
possible microsphere size ranges are between 10μm to 400μm in diameter. This objective 
will provide information, which can lead to the selection of materials and flow 
parameters for uses based on the needs of future researchers. Our findings will be applied 
to the next objective, cell encapsulation.   
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Objective 3 
Encapsulate viable hMSCs inside multi-stimuli responsive alginate microspheres 
using the fabricated MFDs. The final objective will aim to suspend hMSCs in a stimuli 
responsive alginate solution. This solution will be pumped into a MFD at a flow rate 
determined in objective two. The microspheres produced will be collected and 
crosslinked. Cell viability data will be collected from cells within the microspheres at 
different time points.  
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CHAPTER 2: FRABRICATING THE MICROFLUIDIC FLOW FOCUSING 
DEVICE  
2.1. Introduction  
This fabrication process is a continuation of work started as an honors thesis 
previously written by Sam Hoteling [36].The channel design and photomasks were 
previously selected. The photomask determines the channel design, in the field of 
microfluidics this design is said to be flow focusing. Photolithography techniques in this 
section were modified for the purpose of improving MFD quality and fabrication yield. 
2.2. Materials and Methods 
2.2.1. Photolithography Methods 
Once the necessary materials have been procured, photolithography can begin. 
The Laurell Technologies WS-400B Spin Coater can be set up in a fume hood and 
programmed. Medical grade nitrogen is regulated at 60psi into the spin coater. Program 
“F” is preprogrammed with the optimal settings, with a main sequence speed of 3000rpm, 
as recomemded by the SU-8 2075 photoresist manufacturer. A vacumm pump is attached 
to the spin coater and will be used to hold a 50.8mm x 76.2mm  glass slide in place 
during the coating steps. It is recomended that the glass slide be washed with a glass 
cleaner, and dried with filtered compressed air. For best results, dehydrate the glass slides 
at 120C˚ for 5 minutes.  
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A clean glass slide is placed on the head of the spin coater, and the vacuum is 
then activated. SU-8 is poured form the bottle in a 3ml volume onto the center of the 
glass slide. The lid on the spin coater is closed and the program is activated. After 35 
seconds the rotating glass slide comes to rest with a uniform layer of SU-8 coating it in a 
thickness of 70µm. The temperature of the environment has an effect on the thickness.  
The vacuum is deactivated and the glass is moved onto a hot plate with crucible tongs 
and covered with a petri dish. The petri dish confines the air space around the slide, this 
keep the temperature more constant allowing for less distortion of the vicious SU-8 
coating. It also protects the surface from dust and other contaminants.  
The coated slide is then pre baked at 65C˚ for 5 minutes and removed from the 
hotplate to cool for 2 minutes before another baking step at 95C˚ on a second hot plate to 
slightly harden the photoresist.  After another 2 minutes cooling phase the coated slide 
can withstand contact from a photomask being placed on top of it. The mask contains the 
microchannel design, and can block UV light from the Intelli-Ray 400 Ultraviolent Lamp 
from reaching the SU-8 coating. Two simple flow focusing designs were chosen to study, 
one with a 30µm junction, and one with an 8µm junction. It is important that the photo 
mask sits level on top of the prebaked SU-8 coated glass slide. Any deviation from being 
coplanar, and or disance from the surface can deform the exposed design.  
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Figure 4: A general photolithograph process, from masking phase to PDMS 
bonding [40]. 
The whole assembly is then illuminated with UV light 15 seconds. Immediately 
after exposure, the channel design is visible in the SU-8 layer. The mask is then removed 
and the slide is placed back on the 65C˚ hot plate for two minutes, and then on the 95C˚ 
hotplate with 2 minutes of cooling allowed in between. It is still important to cover the 
exposed slide with a petri dish while it is on the hotplate.   
The post exposure baked slides are then placed in a large petri dish on top of a 
wave shaker. Ethyl lactate is poured in the dish in enough volume to completely cover the 
coating on the slide. Ethyl lactate will dissolve all the SU-8 that was not crosslinked by 
the UV light. The wave shaker will gyrate for 10 minutes at 60rpm, after which the slide 
is inspected, and if the non exposed SU-8 is removed, then the slide is rinsed once with 
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ethyl alcohol, and then again with isopropyl alcohol. The glass now has a negative image 
of the photomask, in the shape of the channel design. This negative 3-D image is a 
positive mold. Inspections are made under the microscope to see if the junction geometry 
is intact and worth the effort of continuing the fabrication of a microfluidic device. At 
this time the slide can be wrapped up in aluminum foil to keep it clean and protect it, and 
stored for long durations. 
2.2.2. PDMS Mold 
Polydimethylsiloxane (PDMS) is a suitable material to use for micro channel 
creation, Error! Reference source not found. shows the MFD fabrication process.  
PDMS is inexpensive, able to rapidly produce prototypes, and is biocompatible allowing 
the MFDs to fabricate alginate microspheres that can be also biocompatible. [37].  The 
positive molds with be used to create the microchannels in a PDMS layer. PDMS comes 
in the form of a Slygard 184 kit containing an elastomer and a curing agent.   For 
fabricating these devices a 10:1 ratio of elastomer to curing agent is appropriate, although 
for a harder final product a lower ratio can be used. For each device, 25ml of elastomer is 
thoroughly mixed with 2.5ml of curing agent in a 50ml graduated centrifuge tube and 
spun for one minute at 4000rpm. At this time two hot plates are preheated to 100C˚ and 
125C˚. 
The positive molds are placed inside 3D printed baking trays, which are placed 
inside of a vacuum desiccator. Inside of a fume hood, 2µl of Trichlorosilane is added on 
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top of the mold and the desiccator is run for 2 minutes. This vaporizes the 
Trichlorosilane, which then settles in a very thin layer that acts as a mold release for the 
PDMS. Adding the Trichlorosilane is not so necessary because the features of the MFD 
in this study are relatively large and simple, but for designs with greater intricacy, it is 
recommended.  
Open the vacuum desiccator and pour in the 27.5ml of mixed PDMS on top of 
the positive mold in the baking tray. Apply and remove the vacuum in cycles to remove 
most of the air captured in the PDMS. The baking tray(s) are removed from the 
desiccator and placed on the 100C˚ hotplate. After 45 minutes, the baking trays are 
moved to the 125C˚ hotplate for 25 minutes. Set the first hotplate to 150C˚and bring back 
the trays for 10 more minutes. Remove the mold to let it cool.  
A razor knife is used to cut the glass covered in PDMS out of the mold. The 
PDMS layer is trimmed on top of the glass slide in a rectangle slightly smaller than the 
glass itself. This rectangle is slowly peeled off. Three holes are then punched with a 1mm 
biopsy punch, two for each inlet, and one for the exit flow. 
2.2.3. Corona Bonding Treatment 
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The corona treater comes with many attachment heads, but for this application 
the wide surface wand is equipped. A hotplate is preheated to 100C˚.  The PDMS 
rectangle is placed on a table surface with the channel geometry facing up. Next to it, lays 
a fresh clean glass slide. The corona treater is activated and swept over the two specimens 
at a height of a 5mm from the surfaces for 20 seconds. The PDMS is flipped over onto 
the glass surface. Any air pockets are to be squeezed to the edge of the glass.  Bake the 
two sections on the hotplate for 1 hour at 100°C. Without the heat, bonding will not 
occur. Wait 24 hours for maximum strength to form the siloxane bonds. 
 
 
Figure 6: Left: Corona wand treating a piece of glass and a piece of PDMS at once. Right: 
Schematic showing the siloxane bonds formed between glass and PDMS.  
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2.3. Results and Discussion 
 
There were many problems with the fabrication of the MFDs. Anything from 
temperature to spin speed affected the outcome. Cleaning and baking methods also had 
an effect.  
It was found that the temperature of the room, significantly affects the SU-8 
layer thickness produced by the spin coater, which should be carried out at 25°C if 
possible.  Initial layers were as thick as 140µm, which is significantly larger than the 
width of the 30µm or 8µm photo mask junctions.  At temperatures below 20C˚ there were 
difficulties in getting an even layer to form at all. Adding more photoresist on top of the 
glass substrate was tried in combination with increasing the spin speed. Through 
experimental methods, a final spin speed of 3000rpm was chosen yielding a SU-8 layer 
thickness approximately 70µm, measured with a precision caliper. Below in Table 1 can 
be seen the manufacture recommendations for using the SU-8 photoresist and how it 
matches with the observed behavior.  
 
Table 1: Recommendations for SU-8 2075 conditions for varying thicknesses during 
photolithography are shown below.  
  
21 
 
SU-8  
Thickness 
(µm) 
Spin 
Speed 
(rpm) 
Pre 
Bake @ 
65°C 
(min) 
Pre 
Bake @ 
95°C 
(min) 
Exposure 
Time 
(sec) 
Post 
Bake @ 
65°C 
(min) 
Post 
Bake @ 
95°C 
(min) 
2075 
60 4000 0 to 3 6 5 1 to 2  6 
75 3000 0 to 3 9 7 1 to 2  7 
110 2000 5 10 to 20 10 2 to 5 8 to 10 
240 1000 7 45 15 5 15 
 
Reducing the thickness also improved the fidelity of the exposure. At 140µm the junction 
geometries were enlarged. At 70µm it was possible to expose a finer image.  
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There was a problem of the SU-8 coating coming out of the ethyl lactate wash 
and cracking away from the glass.  At time, this problem arises during the PDMS 
molding phase, where the SU-8 delaminates and gets completely surrounded by the 
PDMS. Different methods for cleaning and preparing the glass slides before spin coating 
were experimented with to find if surface preparations would improve bonding. Figure 5 
above shows the comparison between a water and glass cleaner wash, a wash with a 
dehydration bake, and an acetone wash. There were no noticeable difference in 
performance with these cleaning methods. It is suspected that the geometries of these 
micro channels are so large compared to the precision afforded by photolithograph that it 
does not matter in this case. The positive molds are known to be delicate.  
Figure 5: SU-8 bonding to glass with different cleaning methods. Left: water wash 
with glass cleaner. Middle: Water wash with glass cleaner and a 30min 200C°. 
Right: Acetone wash. 
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 During the baking phases, the SU-8 is still quite viscous, air currents and dust 
can disturb and contaminate it. Especially during the pre exposure bake, when a complete 
flat slide was placed on the hotplate, it would appear to develop a wavy texture. A flat 
surface is ideal to place a photomask on and expose evenly. This problem was solved by 
placing a petri dish cover over the SU-8 during baking. It allowed for a more even heat, 
and protection from the flow of the fume hood. 
 It is very important to bake the PDMS and Glass after they have been treated 
with the corona wand and pressed together. The heat helps form the bonds necessary to 
hold the device together under the fluid pressure. Many times the two inlet holes to the 
MFD would bridge between the layers. This is identified by observing oil coming down 
along the alginate stream into the junction. Once this happens there is no way to create 
monodisperse drops, and the device should be discarded.  
 
Figure 6: Diagram of junction orifices to support Table 2. 
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Table 2: Showing six different chip junctions, measured at orifices in µm. Chips 1-5 
are fabricated with a 30µm photomask, chip 6 is fabricated with an 8µm photomask 
as a comparision. The letters a,b,c,d represent the diameter of orifices at the 
junction where channels;  alginate inlet, mineral oil left, mineral oil right, and 
emulsion exit, respectfully meet.   
Orifice 
(µm) Chip 1 Chip 2 Chip 3 Chip 4 Chip 5 Chip 6 
a 96 178 16 280 350 45 
b 77 172 5 267 302 58 
c 89 211 25 286 329 54 
d 96 152 5 268 331 57 
 
The most significant problem in fabrication was maintaining junction quality. Despite 
keeping the methods the same between multiple devices, some would develop as 
expected, some would be wide open, and few would be closed off completely at the 
junction. For a 30µm mask, he junctions ranged b 300µm. Despite improvements to the 
fabrication method, devices have variability, as seen in Figure 5 and Table 2. The MFDs 
still functioned, which will lead to further development on this project. 
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CHAPTER 3: EFFECT OF FLOW PARAMETERS IN MFD 
3.1. Microfluidic Theory 
In a flow focusing device, a continuous flow fluid, sometime called a focusing 
or sheath fluid, meets a dispersion flow fluid at a junction. The dispersion fluid, 
sometimes called a focused fluid, increases in velocity and extends towards the exit, and 
breaks off into a drop. The resulting exiting fluid is an emulsion of uniformly sized drops 
surrounded by the continuous fluid, which once hardened, become microspheres.  
At this small scale we can ignore the effects of gravity. Surface tension and 
viscosity become dominant. The relationship between the two is illustrated in the 
capillary number, Ca=µU/ɣ, where µ is the dispersion fluid viscosity with units Pa*s, U 
is the velocity, and ɣ is the surface tension between the two immiscible fluids. The 
mechanism of droplet formation can be explained by the stretching of the dispersion fluid 
resisting deformation from friction with the oil. The dispersion fluid is stretched along the 
junction orifice, and the surface tension breaks the extended stream to minimize the 
surface area, creating a droplet [38]. 
Viscosity plays an important role in emulsification, liquids with a higher 
viscosity tend to form larger droplets, while lower viscosity fluids tend to form droplets 
that are controllable more so with flow rate adjustments [38]. 
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Surfactants are an important part of microfluidic technology, especially when 
dealing with droplet formation. Adding a surfactant can vastly change the extension flow 
and droplet formation and transport [39]. Not all surfactants have the same effect on the 
flow due to their molecular characteristics.   
Flow focusing devices have four regimes of flow: squeezing, dripping, jetting, and thread 
formation. The regime of interest of this paper is dripping, although all the regimes have 
been observable. There is a large amount of literature on dripping and jetting for a wide 
range of parameters: flow rates, viscosities, surface tension, surface chemistry, channel 
aspect ratios and channel geometry. However, what is often found is that no single study, 
accounts for all the parameters [40]. The complex geometrical features that characterize 
flow-focusing devices have prevented the determination of empirical laws to predict the 
droplet size, distribution, and rate of emission as a function of the key parameters [39].  
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Figure 7: The dispersion fluid, 2% alginate solution, is shown in green, the 
continuous fluid, mineral oil, is shown in yellow. The green dot is the alginate inlet, 
the yellow dot is the mineral oil inlet, and the blue dot is the emulsion exit. 
3.2. Materials and Methods 
Once the fabrication of a MFD is completed, it can be  used to manufacture 
droplets in an emulsion. All tests with MFDs are preformed on the deck of an inverted 
microscope with 10x magnification. The phenomenon is on a scale so small it is hard for 
the human eye to see in detail.  
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The working fluids must be prepared in syringes. The alginate solution will be 
pumped from a 1ml syringe, the oil will be pumped from a 10ml syringe. The syringe 
pumps afford control capability down to one tenth of one µl/min. Make sure the syringes 
have lure lock adapters. The volume of continuous fluid is approximately ten times that 
of the volume of the dispersion fluid. 
The oil solution is mineral oil with a 2% Span80 added as a surfactant. Simply 
add 0.2ml of Span80 to 9.8ml of mineral oil. The Span80 is very viscous, so it must be 
pipetted slowly. The solution is mixed well on a vortexor. It is then centrifuged at 
3000rpm for 1 minute to remove and air bubbles. During centrifuging, it would be 
considered wise to not include the syringe plungers. Add them back in after, invert the 
syringe, and push any air out the lure lock opening.  The syringe is capped, making sure 
no air is inside, to await use. Alternatively the solution can be made in a centrifuge tube, 
and then pulled into a syringe.  
All alginate solutions in this paper were mixed with a 2% by weight 
concentration. This is done best by adding the dry alginate polymer to a centrifuge tube, 
then adding the appropriate amount of solvent, which can be DI water, phosphate buffer 
solution, or cell media. The tube is vortexed until all alginate is dissolved. This is very 
important to ensure that no polymer aggregates can obstruct the micro channel junction 
of the MFD. The alginate solution can then be pulled into the 1ml syringe. In this paper 
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many types of alginate polymers were used in solutions. These solutions, we 
characterized on a TA instruments AR-2000 stress controlled rheometer. 
The main protagonists of the materials in this research is methacrylated alginate 
beta-cyclodextrin (Alg-MA-β-CD); a non-cytotoxic supramolecular material suited for 
drug delivery and cell encapsulation due to the guest-host interaction properties of 
cyclodextrin complexes where hydrophobic interactions happen inside central molecular 
cavities binding guest molecules with van der Waals forces, electrostatic interactions, and 
or hydrogen bonding [41].  
Methacrylic anhydride was reacted with sodium alginate (Protanal LF200 fts) to 
produce methacrylated alginate (Alg-MA) using similar synthesizing techniques 
previously published [42]. A 10 fold excess molar concentration of methacrylic 
anhydride was added to a 1% weight to volume solution of sodium alginate and the pH 
was adjusted to 8.5 using a 5N sodium hydroxide solution. β-CD was grafted onto Alg-
MA using a multi-step process. β-CD was initially reacted with p-Toluenesulfonyl 
Chloride (TosCl) and mixed for 2 hours before precipitating with solid ammonium 
chloride to form 6-ο-monotosyl-6-deoxy-β-CD (β-CD-TosCl). Second, the material was 
reacted with Ethylenediamine at 60 °C for 24 hours to form mono-6-deoxy-6-
aminoethylamino-β-CD (β-CD-EDA). Lastly, the β-CD was grafted onto the Alg-MA 
polymer in 2-(N-morpholino) ethane sulfonic acid (MES) Buffer with N-ethyl-N’(3-
(dimethylamino)propyl) carbodiimide hydrochloric acid (EDC) and N-
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hydroxysuccinimide (NHS) to form Alg-MA- β-CD (see Figure 8). The final material 
was placed on dialysis against DI water for 5 days and lyophilized to obtain a dry 
polymer. The β-CD complex has a hydrophilic exterior surface and a 
lipophilic/hydrophobic interior, which allows for molecules to enter the cavity. To allow 
for crosslinking to occur with visible green light (525mn) an Eosin Y photoinitiator 
system was added, in varying volume percentages, to the polymer solution under red 
light.  
 
Figure 8: Chemical drawings depicting the modification of alginate to Alg-MA and 
again to Alg-MA-β-CD. Also the β-Cyclodextrin structure is shown with its 
simplified conic shape.  
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The rheometer is supplied with compressed air regulated at 25psi. It has a 
protective black spindle covering on the geometry chuck. His is removed and the 20mm 
geometry cone head is tightened onto the spindle. The power supply to the water pump 
and electronics control box is to be activated.  
Using the TA Rheology Advantage software select the 20mm geometry. A 
calibration was performed and the back off distance was set to 20000 microns. The gap 
height was zeroed, as is the normal force. 
Four kinds of test are preformed. Two viscosity tests, one at 25°C and one at 
37°C are programed as continuous ramp flow procedures. The shear rate ranges from 0.1 
to 100 Hz and samples are taken every second for two minutes.  
The third test is an oscillary Calcium chloride time sweep for 10 minutes at 
10Hz with 1% deformed strain. This test is performed at 37°C. One minute into the test, 
Calcium chloride is injected around the geometry head to crosslink the alginate.  
The fourth test is an oscillary temperature sweep. This happens at 1% deformed 
strain and 1Hz. The peltier plate is heated 0.5°C per minute, from 25°C to 37°C. 
The hydrogel is placed on center of peltier plate in a 0.07ml drop and the 
geometry is lowered within 3 mm of sample then set to the gap height. Visual inspection 
of the hydrogel meniscus can tell if there is too much or too little testing material.  It is 
important to characterize and report the material properties before using them. Alg, Alg-
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MA, Alg-MA-β-CD, and Alg-MA-β-CD with 1:1 F108 were studied along with mineral 
oil.  
The syringes are locked into their respected PDH 2000 Infusion syringe pumps, 
each syringe gets a pink 20 gage female lure lock end needle. These needles plug inside 
polytetrafluoroethylene (Teflon) tubing. It takes approximately 15cm of tube length to 
reach each inlet of the MFD on the microscope. The exit flow of the MFD will require 
approximately 6cm of tubing which must be bent in an arc more than 90 degrees so 
emulsion drops can form and fall in a collection bath, which would be a 15ml or 3ml 
centrifuge tube, with varying solutions depending on the case. Telfon tubes will plug into 
the punched holes in the PDMS layer. 
  
 
3.3. Results and Discussion 
First tests were conducted with just DI water and mineral oil. This proved the 
device would function and led to the research with alginate solutions and allowed for 
fabrication of devices to continue. 
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Figure 9: Mineral oil with and without 2% Span80 at 25°C and 37°. This shows that 
adding the surfactant doesn’t change the viscous behavior. 
Mineral oil in the solutions used in this paper were tested on the rheometer. The results 
can be seen about in Figure 9. All alginate solutions were also tested. Each sample was 
run in 5 trials and all with a 2% concentration as seen in Figure 10. 
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Figure 10: 2% Alginate solution average viscosities at 25°C and 37°C showing a 
slight temperature dependence.  
Drops were formed with a 2% sodium alginate solution. The emulsion these 
drops were formed in, was dropped directly into 1M Calcium chloride. This was met with 
limited success, due to coalescence of the drops in the emulsion before they exited the 
device.  This problem was mostly solved by adding a surfactant, Span80, to the mineral 
oil, in a 2% concentration.  Microspheres were captured and washed from the mineral oil 
by adding isopropyl alcohol and centrifuging at 3000rpm for 1 minute. The centrifuged 
test tube contained a pellet of microspheres. As much supernatant fluid was poured off as 
possible without sacrificing the microspheres. The microspheres were washed in 
isopropyl alcohol and suspended and centrifuged 2 more times, followed by three similar 
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washes in DI water. This is necessary because the microspheres went aboard the 
lyophilizer to become dehydrated for SEM imaging.  
 
 
The external gelation is so fast that deformed microspheres with chocolate chip style tails 
are often observed due to the deformation when the droplets transfer from the oil phase to 
the Calcium chloride bath [Li Liu]. This phenomenon was observed in early trials.  
This led to an experimental modification with 2% calcium carbonate mixed into 
the mineral oil. This was an attempt to crosslink the drops as they were being formed and 
solve the coalescence and tail problem. Instead due to the sensitive nature of fluids flows 
near the junction, the alginate was crosslinked inside the device, lending it inoperable. 
The calcium carbonate method was abandoned.   
The next material that was used in the MFD was 2% Alg-Ma, chosen for its 
ability to be green light crosslinked. This was a more novel approach to creating an 
Figure 11: Left: 2% Na-Alg Microspheres after calcium chloride bath crosslinking. Right: 
SEM after washing and lyophilizing 
  
36 
 
alginate microsphere, without the Calcium chloride bath. Crosslinking a drop as it was 
formed would also prevent coalescence and deformation from dropping into a collection 
bath. However this material is multi responsive and still can crosslink with the Calcium 
chloride and was done with the same method as using just alginate to illustrate its multi-
functionality.  
 
Figure 12: 2% Alginate solution with 2% F108 is shown with average viscosities at 
25°C and 37°C. 
2% Alg-MA-β-CD with a weight to volume 2% F108 was used as the dispersion 
fluid in some tests. F108 is a pluronic that had large interest in the drug delivery field.  
This material seemed to be dissimilar and unbounded with the alginate. Although F108 
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needs the CD group to bond to alginate, solutions with the other types of alginate were 
made and tested for thoroughness as seen in Figure 12.  As a result, monodisperse 
droplets were not possible. In order to maintain the use of the Alg-MA-β-CD, the stimuli 
responsive material, F108 was no longer used for the rest of this study. Its uses are still 
under investigation.  
 
Figure 13: 2% Alginate solutions with and without 2% F108 are tested at varying 
shear rates and  viscosities at 25°C and 37°C are recorded. 
2 % Alg-MA-β-CD was run without the F108. This material was selected to move. on 
with the cell study because of its stimuli responsive qualities, and its performance in the 
MFD. Figure 13 shows all the alginate materials that were considered. A flow parameter 
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analysis was performed by controlling the continuous flow input and the dispersion flow 
input and recording the observed drop diameter.  This was done in a range for both flows, 
changing the ratio of the two inlet flow rates. Dispersion flow rates were varied from 
0.0001ml/min to 0.0005ml/min in 0.0001ml/min increments. Continuous flow rates were 
varied from 0.0065ml/min to 0.008ml/min in 0.0005ml/min increments. Data was 
recorded for the six devices seen in Figure 17.  
 
Figure 14: Average 2% alginate solutions with calcium chloride introduced at 1 
minute.  Crosslinking can be observed as G’ dominates G”. 
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After determining the material viscosities as a function of shear rate. The 
Rheometer was used to find the gelation effects of adding calcium chloride to the alginate 
solutions. The alginate solutions were loaded like before onto the peltier plate, and shear 
storage and shear loss moduli (G’ and G”) data was acquired for 10 minutes. At the one 
minute mark, 1M calcium chloride was added and the effect is apparent in Figure 14. A 
material becomes a hydrogel, once G’ crosses above G”. The intersection of these curves 
is known as the gelation point.  
 
Figure 15: The red points show the Alg-MA-β-CD with a 1:1ration of F108. The 
crosslinking happens at around 27C°. Notice the control, without F108, also has 
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elastic properties dominating a around 33C°, this can be attributed to dehydration 
of the maerial. 
 The green light crosslinking times for 2% Alg-MA-β-CD were determined for 
varying concentrations of photoinitiator; triethanolamine. The fastest acting concentration 
was when 5% by volume was added to the alginate solution. The experiment was in 
darkness or dim red light. The green light was activated at 30 seconds. The tests were 
performed at 1% deformed strain and 1Hz for 3 minutes. The results of these tests can be 
witnessed below in Figure 16. 
 
Figure 16: Effects of Changing Concentration of Triethanolamine (TEOA) in 2% 
Alg-MA-β-CD on Crosslinking Time 
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Below in Figure 17 are the junctions of six MFFDs, the first five are generated 
from a 30µm photomask, the sixth is from an 8µm photomask. Note that there is great 
variation in the fabrication yield. Device 4 restricted fluid flow, and was unusable. 
Device 6 delaminated due to fluid pressure during testing. These devices were used in a 
study to determine the effects of the flow rates on micro-droplet size. 
 
Figure 17: Photos of the Junctions of MFDs used in Table 2 
For each MFD, the flow rates were adjusted on the syringe pumps, and a minute 
was given for the droplet phenomenon to stabilized. A photograph was taken of the 
droplets being produced. This was done for every flow rate combination. The photos 
were uploaded into Image J photo analysis software, where the diameter of the drops 
could be measured with optical techniques. Note that some of the drops are discoids and 
not spheres.  
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Table 3: Varying Flow Parameters and Observing Droplet Size 
Microsphere Size 
Changes based on 
Flow Parameters 
Continuous 
Flow 
(0.0065ml/min) 
Continuous 
Flow 
(0.007ml/min) 
Continuous 
Flow 
(0.0075ml/min) 
Continuous 
Flow 
(0.008ml/min) 
MFD 
Number 
Dispersion 
(2%AlgMA-
β-CD) Flow 
Rate 
(µl/min) 
Microsphere 
Size (µm) 
Microsphere 
Size (µm) 
Microsphere 
Size (µm) 
Microsphere 
Size (µm) 
1 
0.1 82.1 92.2 67.5 81.7 
0.2 72.7 103.3 81.6 70.4 
0.3 81.5 101.6 85.6 123 
0.4 105 
   
0.5 
    
2 
0.1 144.3 110.9 108.7 119.9 
0.2 158.7 117.6 125.7 152 
0.3 155.7 199.8 132.4 195.6 
0.4 174.6 145.9 143.9 162.8 
0.5 272.5 231.4 214.4 196.8 
3 
0.1 
    
0.2 
    
0.3 
    
0.4 
    
0.5 
    
4 
0.1 394.6 256.7 473.7 445.9 
0.2 390.7 235.8 357.5 394.7 
0.3 399.6 285.7 428.6 431.5 
0.4 430.3 489.7 290 417.5 
0.5 450 475.4 404.7 416.8 
5 
0.1 394.2 429.5 442 406.5 
0.2 405.7 473.6 533.8 481.1 
0.3 446.9 490 477.5 559.4 
0.4 471.9 549.2 518.1 586.1 
0.5 491.2 555.4 513.5 553.1 
6 
0.1 104.5 
   
0.2 117.9 
   
0.3 134.7 
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0.4 129.4 
   
0.5 131.5 
   
 
 Table 3 is a breakout of Table 2 to make it easier to show along with Figure 18. 
It is important to understand that with this material it is rare to witness long durations of 
monodisperse droplet generation. It would seem as if the material was not a 
homogeneous solution. It is a frequent phenomenon to observe MFD junction obstruction 
with this material. Most of the time the junction can be cleared by adding a temporary 
impulse to the flow, or by deforming the PMDS above the junction inward. The 
mechanism that causes clogging, even in openings larger than particle size, is a complex 
problem that previous researchers have not been able to solve [43]. 
 
Table 4: Varying Flow Parameters and Observing Droplet Size of Device 2. 
Microsphere Size 
Changes based on 
Flow Parameters 
Continuous 
Flow 
(0.0065ml/min) 
Continuous 
Flow 
(0.007ml/min) 
Continuous 
Flow 
(0.0075ml/min) 
Continuous 
Flow 
(0.008ml/min) 
MFD 
Number 
Dispersion 
(2%AlgMA-
β-CD) Flow 
Rate 
(ml/min) 
Microsphere 
Size (µm) 
Microsphere 
Size (µm) 
Microsphere 
Size (µm) 
Microsphere 
Size (µm) 
2 
0.0001 144.3 110.9 108.7 119.9 
0.0002 158.7 117.6 125.7 152 
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0.0003 155.7 199.8 132.4 195.6 
0.0004 174.6 145.9 143.9 162.8 
0.0005 272.5 231.4 214.4 196.8 
 
 
Figure 18: Photos of MFD Drop Generation for Device 2 at Varying Flow Rates 
Above in Figure 18 are gathered images of device 2 during each flow condition. 
Increasing the dispersion fluid flow rate increases drop size. Increasing the continuous 
flow fluid decreases drop size. This matches microfluidic theory. Each photo corresponds 
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with the cell in Table 3. Also note, that the 2% Alg-MA-β-CD did not produce 
monodisperse drops.  
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CHAPTER 4: CELL ENCAPSULATION 
4.1. Introduction 
Human mesenchymal stem cells (hMSCs) are of top interest to tissue engineers. 
They are widely available and can be harvested and cultured directly out of human bone 
marrow.  hMSCs have the ability to differentiate into osteoblasts, adipocytes, 
chondrocytes, muscle cells, and stromal fibroblasts [23, 44].  
Transplanting stem cells by means of local injection has seen limited clinical 
success [21].  This method’s drawback become apparent starting at the injection, and 
problems persist during the tissue regeneration process. Injecting only stem cells 
suspended in a liquid solution exposes them to high shear forces that can damage the cell 
membranes. This can severely decrease cell viability to 40-50%. After injection, without 
mechanical supports to promote adhesion, the cells tend to settle in the cavity or defect. 
The function and long-term survival of the injected cells is diminished without an extra 
cellular matrix to transmit mechanical signals which are responsible for proliferation, 
migration, secretion, and differentiation [21, 23].   
The use of a hydrogel can help solve these problems. Injected cells suspended in 
a hydrogel can be protected from shear forces within the needle. The hydrogel matches 
the desired properties of the extra cellular matrix. Alginate hydrogels can be modified to 
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interact with cells, acting like a ligand and promoting cell adhesion. Cells can spread in 
an even distribution without aggregation within the cavity or defect.  
 
 
Figure 19:  Hydrogel as a Cell Scaffold [21] 
 
 
4.1.1. Live/Dead Assay for Cell Encapsulation  
In order to test the viability of cells encapsulated in Alg-MA-β-CD via the MFDs a live/dead 
assay stain will be used. The two dyes used in this kit are Calcein AM (component A) and 
ethidium homodimer-1 (component B). The principal method behind the kit is as follows:  
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 “Live cells are distinguished by the presence of ubiquitous intracellular esterase activity, 
determined by the enzymatic conversion of the virtually nonfluorescent cell-permeant calcein AM 
to the intensely fluorescent calcein. The polyanionic dye calcein is well retained within live cells, 
producing an intense uniform green fluorescence in live cells (ex/em ~495 nm/~515 nm). EthD-1 
enters cells with damaged membranes and undergoes a 40-fold enhancement of fluorescence 
upon binding to nucleic acids, thereby producing a bright red fluorescence in dead cells (ex/em 
~495 nm/~635 nm). EthD-1 is excluded by the intact plasma membrane of live cells. The 
determination of cell viability depends on these physical and biochemical properties of cells. 
Cytotoxic events that do not affect these cell properties may not be accurately assessed using this 
method. Background fluorescence levels are inherently low with this assay technique because the 
dyes are virtually non-fluorescent before interacting with cells [46].”  
Live cells will fluoresce green because component A (green dye) will pass through a living cell 
membrane and interact with calcein that is held within. The dead cells have damaged cell 
membranes which allow component B (red dye) to enter the cell and interact with nucleic acids in 
the cell. Component B cannot enter the living cells because it cannot pass through an intact cell 
membrane.  
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Figure 20: Live/Dead assay fluorescence. Component A is green, Calcein AM, and 
component B is red, ethidium homodimer-1. The green dye stains all cells; the red dye 
stains only dead cells, but fluoresces forty times brighter than the green.  
 
 
 
4.2. Materials and Methods 
The hMSCs were first be cultured, this starts with recovering frozen cells. Growth media 
is warmed to 37°C in a water bath. The stem cells are removed from a liquid nitrogen 
dewar, and placed directly in the 37°C water bath. Add the thawed cells with 6ml of 
growth media into a 15ml centrifuge tube and centrifuge at 600rpm for 10 minutes. The 
growth media is then aspirated away from the cell pellet. Frozen cell samples commonly 
stored in a 1ml volume that contain 1 million cells. The cell pellet is resuspended in 
1.5ml of growth media. 500µl of this cell suspension is added to each of three T75 flasks. 
This seeds the flasks with 1/3 million cells. Add 10-12ml of growth media to each flask 
and place the flasks into a cell incubator at 37°C. After one day, the growth median has to 
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be aspirated off and replaced. The media must continue to be changed ever 3-5 days until 
cells reach 90% confluency.  
When the cells reach 90% confluency, they must be passaged, or in other words, 
subcultured. This is accomplished by aspirating off the cell media in the flasks. 4ml of 
trypsin is added to each flask, this will break down proteins that attach cells to the flask 
bottom, allowing them to dissociate. While this is happening the flask is incubated for 8 
minutes. 4ml of cell media is added to counter act the effects of the trypsin. This solution 
is suspended and added into a 50ml test tube and centrifuged at 600rpm for 10 minutes. 
The tube is then aspirated again, and a cell pellet remains.  
The cells can then be counted and either spread out amongst new flasks, or if there are 
10million/ml then used in a cell encapsulation study. To do this it is required to mix 2% 
Alg-MA-β-CD solution in cell media. At the minimum this requires 0.8ml of cell media 
and 0.02g of lyophilized Alg-MA-β-CD. This solution must be mixed thoroughly and 
centrifuged for 1 minute at 3000rpm to remove any air.  
In a dark room, working under red lights in a biosafety cabinet, photoinitiators are added 
to the mixture. 50µl of 5M triethanolamine (initiator, TEOA) is added to the polymer 
solution and mixed through before the 5µl of eosin Y (photosensitizer, EY) in 1-vinyl-2-
pyrrolidinone (catalyst, 1VP) solution is added. To obtain a polymer solution with a cell 
density of 2 million cells/ml, add 200µl of the 10 million cells/ml cell stock solution. This 
solution is then transferred to a 1ml lure lock syringe.  This 1ml syringe now contains 2 
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million cells suspended in 2% Alg-MA-β-CD in cell media solution with photoinitiators, 
so it can crosslink b exposure to green light. This 1ml syringe is placed into the syringe 
pump as previously described and the cell containing polymer solution is pumped 
through a MFD. The microspheres were collected in varying concentrations of calcium 
chloride and cell media. A schematic of this process can be seen in Figure 21. 
 
Figure 21: A visualization of the experimental set up used to encapsulate hMSCs 
inside a MFD using 2% Alg-MA-β-CD and green light and calcium chloride 
crosslinking. 
While the MFD was manufacturing microspheres, the Live/Dead Cell Imaging 
Kit is prepared. The kit comes as a two part stain, Calcein fluoresces green at 
(494/517nm), and Ethidium homodimer-1, which is the presence of DNA fluoresces red 
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at (528/617nm). The kit is stored at -20°C and in the dark. The Calcien comes in a 1ml 
1µM solution marked with a green cap. The Ethidium comes in a 1µl volume in a tube 
with a red cap. Once the tubes are thawed, pipet all of green capped tube into the red 
capped tube and mix the solution. This creates a 2X working solution which then can be 
added to cell solutions within 2 hours. The cells must sit with the stain for 15 minutes at 
25°C. Then they are suspended and pipetted in a 10ul volume onto each side of either a 
reusable or a disposable hemocytometer. The hemocytometer is inserted into a Countess 
II Automated Cell Counter, with contains difference light sources to fluoresce the stains.  
The green stain is permeable to cell membranes and can dye a cell. The red stain 
becomes 40 times as fluorescent as the green, once it binds to a nucleic acid in the cell 
nucleus.  This can happen in a dead cell, where the cell membrane is compromised. A 
living plasma membrane excludes the red stain. 
4.3. Results and Discussion 
The MFD generated micro drops of 2% Alg-MA-β-CD into mineral oil with 2% 
Span80 containing 2million cells per ml of passage 5 hMSCs. This emulsion, although 
capable of gen like cross linking, was dropped into a 1M calcium chloride and isopropyl 
alcohol collection bath. The isopropyl alcohol was used to wash the oil from the 
microspheres. As expected the collection bath mixture was killing the hMSCs inside the 
microspheres. Cells in the control were highly viable at comparable time points. Figure 
22 shows the fluorescence of the dead stain in cells encapsulated by a microsphere.  
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Figure 22: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~1 hour after the cells were added to the Alg-MA--CD and crosslinked in 
1M calcium chloride a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube 
d.) Magnified image of dead (red fluorescent) encapsulated cell 
The next experiment was the same, except the collection bath contained only 
cell media and the cells used this time were passage 6. After 30 minutes of collection, the 
green LED light was activated to crosslink the microspheres. In Figure 23 however, upon 
viewing the fluorescent images it appears as if the hMSCs were washed out of the Alg-
MA-β-CD drops. This result is intuitive because the 2% Alg-MA-β-CD solution 
encapsulating the cells would have just dissolved into the cell media. What was left in the 
bottom of the bath was a combination of live and dead free floating hMSCs.  
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Figure 23: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~2 hours after the cells were added to the Alg-MA--CD and failed to 
crosslink into microspheres under intermittent green light, but still proved cells 
could survive the process and remain at room temperature for 2 hours in the Alg-
MA--CD material. a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube 
d.) Magnified Green/Red Overlay of Bright Field  
 
In an attempt to draw crosslinked microspheres from the oil layer, before they 
had a chance to sink into the denser cell media, Figure 24 was obtained. Although no 
information on cells or alginate microspheres was procured, it was discovered that oil 
drops would interact with the red stain. There is no current explanation for this 
phenomenon.  
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Figure 24: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~4 hours after the cells were added to the Alg-MA--CD and failed to 
crosslink into microspheres and it was discovered that the mineral oil with 2% 
Span80 has a red fluorescence from either the material properties or uptakes the 
live/dead stain used. A.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube 
d.) Magnified Green/Red Overlay of Bright Field 
 
The next experiment was run with continuous green light. This time a lower 
molar concentration of 0.4M calcium chloride was added to the collection bath. Instead 
of having isopropyl alcohol wash the oil away from the microspheres, the collection tubes 
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were centrifuges at 1000rpm for 1 minute. The oil and cell media was then aspirated of 
the top leaving a pellet of microspheres. 200µl of the Live/Dead solution was added and 
30 minutes was given until the sample was analyzed.  
Live cells were found (Figure 25) inside the 2% Alg-MA-β-CD microspheres. It 
had been 12 hours since the cells left their incubator to be collected and put in room 
temperature 2% Alg-MA-β-CD. This may suggest that the alginate solution and or 
microspheres offered some form of protection.  
 
 
 
Figure 25: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained 12 hours after the cells were added to the Alg-MA--CD and crosslink into 
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microspheres under constant green light and in a 0.4M calcium chloride and cell 
media bath. a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube d.) 
Magnified Green/Red Overlay of Bright Field 
 
 
Figure 26: A Countess II Automated Cell Counter with fluorescent capabilities was 
used to image Alg-MA--CD microspheres produced in MFDs. These images were 
obtained ~13 hours after the cells were added to the Alg-MA--CD and crosslink 
into microspheres under constant green light and in a 0.01M calcium chloride and 
cell media bath a.) Bright Field View b.) GFP Light Cube c.) RFP Light Cube d.) 
Magnified Green/Red Overlay of Bright Field 
 
The experiment was preformed again with a 0.01M calcium chloride and cell media 
mixture in the collection bath.   The green light was active the whole time.    2% Alg-
MA-β-CD   microspheres were still crosslinked and preserved through the washing steps. 
The hMSCs were once again found to be viable within the  alginate hydrogel, this time 
13 hours had passed with the cells in solution at room temperature.     
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK 
5.1. Objective Conclusions 
Objective 1 Conclusions 
Although many reliable and functional MFDs were fabricated by modifying existing techniques 
and methods, the devices are not optimal. Photolithography does not always produce the same 
junction shape, or have the shape be the correct photomask dimensions even with careful glass 
cleaning and baking precautions. A long operating duration is possible to achieve, due to the 
strength of corona treatment bonding. Junction blockage can be mitigated by ensuring alginate 
solutions are homogenous and well dissolved. Monodisperse alginate microspheres are possible 
to achieve for homogeneous alginate solutions.  
Objective 2 Conclusions 
A large amount of material research was conducted. It was found that the 2% alginate 
solutions used in the MFDs have a shear thinning property, Going into the junction the 
fluid is seen to flow with less resistance. It was also discovered that a 5% by volume 
Triethanolamine photoinitiator alginate solution proved to have the fastest crosslinking 
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time under green light when compared to other percentages. calcium chloride however 
was found to have the fastest and stiffest crosslinking response.   
It was found that an increase in dispersion flow will increase the size of droplet that gets 
formed. An increase in continuous flow, will decrease the size of droplet. To produce a 
desired size droplet, activate the syringe pumps with experimentally determined flow 
rates that match the size. In order to encapsulate hMSCs a desired droplet size was 
150µm was chosen, and from Table 4 dispersion flow of 0.0004ml/min and continuous 
flow of 0.008ml/min. A photomask with a 30µm junction orifice was chosen, rather than 
the available 8µm, to make the MFDs that would be used in cell encapsulation. A larger 
junction physically allows hMSCs to pass through, and for larger droplets to form.   
Objective 3 Conclusions 
Viable hMSCs were encapsulated successfully in a multi-stimuli responsive 2% Alg-MA-
β-CD solution using fabricated MFDs with a 30µm junction. Microspheres were 
crosslinked with green light and calcium chloride. Green light alone was not quick 
enough to crosslink the Alginate before it was dissolved in the collection bath. A low 
molar concentration of calcium chloride however was able to crosslink the microspheres 
without killing the cells. The results were confirmed with fluorescence imaging of a 
live/dead stain.   
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5.3. Future Work Recommendations 
Techniques other than photolithography should be researched to create 
crosslinked alginate microspheres. Devices can be rinsed with isopropyl alcohol and 
reused, but investigations should be made to changes in channel surface conditions prior 
to use. Further microsphere production will have to be at a higher output due to the time 
sensitive nature of the encapsulated cells if larger scale experiments are to be performed.   
The varying dispersity of 2% Alg-MA-β-CD should be investigated. Furthermore, 
the generation and control of droplets with high uniformity and large variety in diameter 
is yet to be demonstrated and understood[47]. Further research into the addition of F108, 
or alternative pluronics, into the alginate solution could still offer scientific benefit. A 
more efficient green light crosslinking method could be employed to eventually remove 
the need for a calcium chloride collection bath.  
A time study should be performed on encapsulated hMSCs to determine if the 
microsphere environment will allow for cell ligand attachment, proliferation, and 
potential differentiation. Confocal microscopy should be used to generate 3D images of 
encapsulated cells and determine their viability.  
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APPENDICES 
 Manuals/Protocols 
 Standard Operating Procedure: Production of a MFD Using Soft Photolithography 
MATERIALS:  
• SU-8 2075 
• Slygard 184 kit ( PDMS) 
• (Tridecafluoro-1,1,2,2-Tetrahydrooctyl)Trichlorosilane 
• Corona Surface Treater (Electro-Technic)   
• Crucible Tongs 
• Ethyl Lactate 
• Ethyl Alcohol 
• Isopropyl Alcohol 
• 50.8mm x 76.2mm x 1.2mm glass slide 
• Glass cleaning solution 
• Gloves (Nitrate KC500) 
• Compressed Nitrogen tank (medical grade) 
• Deionized water 
• Laurell Technologies WS-400B Spin Coater 
• Hot Plate (2) 
• Intelli-Ray 400 Ultraviolent Lamp 
• Large Petri Dish 
• Luar Fittings  
• Photomask 
• Safety Glasses 
• Starstedt Mini Wave Dancer 
• UV Goggles  
• Vacuum camber 
• Wave Shaker 
• 10ml Syringe 
• 50ml Centrifudge Tubes 
• 1mm Biopsy Punch 
METHODS: 
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Creating the Mold 
1) Program the spin coater: 
a. For SU-8 the spin coater should be programmed to run a cycle similar to the 
steps seen in the table below. 
 
 
Duration (s) Speed (rpm) Acceleration (rpm/s) 
0-10 500 100 
10-30 3000 300 
30-35 0 ** 
     ** The spin coater will decelerate automatically in the last step. 
 
2) Clean the slide 
a. Wash the glass slide with a glass cleaner. 
b. Rinse the glass slide with DI water and let dry. 
3) Coat the slide 
a. Use aluminum foil on the inside of the spin coater to prevent it from getting 
coated with SU-8 as it is hard to remove from a surface. 
b. Place the spin coater in the fume hood.  Connect it to the N2 tank and vacuum 
pump before turning it on.  
c. With the regulators closed, open the N2 tank main valve. 
d. Open the regulator and set the pressure going into the spin coater to 60 psi. 
e. Load the spin coater program.  
f. Center a cleaned glass slide on the head of the spin coater 
g. Turn on the vacuum pump attached to the spin coater.  Press the vacuum 
button on the spin coater to control the vacuum on the glass slide. Insure the 
vacuum is strong enough or else the spin coater will not run.  
h. Check the hoses for leaks. 
i. Make sure fume hood is turned on. 
j. Add 3ml of SU-8 to the center of the glass slide in the spin coater. It is very 
viscous, best to pour from bottle. 
k. Close the lid and run the program. Program “F” is preprogrammed.  
l. Once the spin coater head has stopped spinning, open the lid, gently grip the 
glass slide. Turn off the vacuum to the head and release the glass slide. 
m. Use a razor to remove any excess material from the edges. 
n. Close Nitrogen tank, and turn off vaccum. 
4) Soft Baking 
a. Pre heat hot plates, one to 65 ̊C, another to 95 ̊C. 
b. During all baking steps cover the SU-8 slides with an upside-down petri dish. 
c. Bake coated glass slide at 65  ̊for 5 minutes. 
d. Transfer coated glass slide with tweezers to a drying rack to cool for 2 
minutes to room temperature before proceeding. 
e. Transfer coated glass slide with tweezers to second hot plate. Bake at 95 ̊C for 
10 minutes. 
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f. Transfer coated glass slide with tweezers to a drying rack to cool for 2 
minutes to room temperature before proceeding. 
g. Examine surface coating for irregularities, if the SU-8 is not flat repeat steps 
4a-4e. 
h. Keep hot plates on for post exposure baking step. 
5) Exposure  
a. Turn on the IntelliRay UV lamp, and let it warm up. 
b. Tape the photomask over the SU-8 coated slide and to the deck of the UV 
lamp. 
c. On the lamp interface select 100% intensity and a time of 15 seconds.  Once 
you hit “enter” the shutter will open and expose the slide.   
d. Make sure the protection shield is in place and you are wearing the UV 
goggles. Press “enter” to expose the slide. 
6) Post-Exposure Baking 
a. Remove the photomask from the glass slide. 
b. Place the exposed slide onto the 65 ̊C hot plate for 2 minutes. 
c. Transfer exposed glass slide with tweezers to a drying rack to cool for 2 
minutes to room temperature before proceeding. 
d. Place the exposed slide onto the 95 ̊C hot plate for 8 minutes. 
e. Transfer exposed glass slide with tweezers to a drying rack to cool for 2 
minutes to room temperature before proceeding. 
f. Turn off hot plates. 
7) Development 
a. Place the baked slide into a large petri dish. Put the petri dish in the wave 
shaker which will be in the fume hood.  
b. Pour ethyl lactate into the petri dish until SU-8 on glass slide is covered. 
c. Gyrate for 8 minutes at 60 rpm or until the channels are clearly visible. A 
mold is now created. 
8) Rinse and Dry 
a. Carefully remove the mold from the petri dish.  Dispose of ethyl lactate into 
waste container.  
b. Rinse over a second large petri dish with ethyl alcohol for 10 seconds. 
c. Rinse with isopropyl alcohol for 10 seconds and let dry. 
d. Wrap mold in tin foil to prevent dust contamination. 
 
Creating the PDMS Channel 
 
9) Mix PDMS 
a. Combine 25ml Slygard 184 elastomer and 2.5 ml Slygard 184 curing agent in 
a 50ml graduated centrifuge tube. 
b. Thoroughly mix the two components. 
c. Place the mixed tube in the centrifuge making sure to counter balance the 
rotor. 
d. Centrifuge the PDMS for 30 seconds at 4000 rpm. 
e. Place the mixed tube in a rack in the fume hood. 
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10) Coat the mold with release  
a. Place the mold in the vacuum chamber into a 3d printed tray in a petri dish. 
b. Add 2ul of (Tridecafluoro-1,1,2,2-Tetrahydrooctyl)Trichlorosilane on top of 
the mold. 
c. Apply a vacuum to vaporized and settle a thin layer of Trichlorosilane on the 
surface. 
d. The Trichlorosilane is not really necessary for simple designs, it is used as a 
PDMS release for more complicated and intrcate geometries.  
11) Fill the mold 
a. Open the vacuum desiccator and pour in PDMS mixture slowly to prevent 
proliferation of bubbles so that it fills the tray and covers the mold. 
b. Apply a vacuum again until all bubbles have been drawn out of the mixture. 
12) Bake the mold 
a. Preheat a hot plate to C; preheat the other hot plate to 125 C̊. 
b. Bake for 45 minutes at 100 C̊, relocate mold to other hot plate. 
c. Bake for 25 minutes at 125 C̊ and switch first hotplate to 150 ̊C 
d. Put mold back on first hotplate and bake for 10 minutes at 150 C̊ 
e. Remove mold and let cool. 
13) Preparing the MFFD 
a. Trim PDMS to the size of a glass slide and remove it from the mold.  
b. Use 1mm biopsy punches to cut 3 holes in the device where a Teflon line will 
plug into. 
 
Bonding PDMS to Glass 
 
14) Corona Treatment 
a. Get the corona treater out of the box, plug it in, and attach the wide surface 
wand. It resembles a shaving razor.  
b. Preheat a hotplate at 100 C̊. 
c. Lay the PDMS rectangle on a table surface with the channel geometry facing 
up. 
d. Next to it, lay a fresh clean glass slide. 
e. Turn on the corona treater and sweep over the two specimens, at a height of a 
quarter inch from the surfaces for 20 seconds.  
f. Flip the PDMS over onto the glass surface. Squeeze any air pockets to the 
edge. 
g. Bake the two sections on the hotplate for 1 hour. Without the heat, bonding 
will not occur.  
h. Wait 24 hours for maximum strength 
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 Standard Operating Procedure: Rheo-Visco-Alg-MA-β-CD-Testing 
MATERIALS:  
• 1ml syringe 
• 70% Ethanol 
• DI water 
• Desposible wipes 
• Gloves 
• Test soluions 
METHODS: 
 
Rheometer Start-Up 
1) On the regulator attached to the in-house compressed air valve, release the 
sliding metal lock, and pull the valve to be vertical (parallel to flow of air). 
a. For the filter attached the wall, turn that valve to be parallel to the green 
tubing. Ensure that the regulator reads approximately 25 psi.  
2) Unlock spindle on top of rheometer (left to loosen), while holding the black 
cap 
a. Ensure bearing is freely moving 
3) Attach 20mm geometry onto geometry screw, tighten using spindle on top. 
4) Switch on power strip supplying the water pump and the rheometer. A system 
check will be initiated as shown by the LCD on the electronics control box. 
a. Water bath is filled with incubator water.  
5) Open TA Rheology Advantage software on desktop 
6) Select the Instrument Status screen in the software 
7) Select desired geometry from list at top of program 
a. Hydrogels primarily use the 8 mm parallel plate geometry (already set-
up) 
b. To add a new geometry, click on Geometry menu, then New. Follow 
on-screen instructions to set-up the computer for the desired geometry. 
8) Selected geometry  Settings  Geometry inertia  Calibrate 
a. Perform calibration for every experiment 
b. Set Back-off Distance = 20000 micro m 
9) Lower the head using the buttons in the software or the arrow buttons on the 
base of the rheometer to about 5 mm above the base plate 
10) Zero the gap 
a. Instrument  Gap  Zero Gap 
b. Do NOT zero the instrument with the sample on the plate 
11) Return to back-off distance after the gap has been zeroed 
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12) Zero the normal force 
a. Instrument  Normal Force  Zero force 
13) Select a pre-programmed procedure or experimental protocol 
a. To create a new procedure: Procedure  New  Stress relax (ex) 
i. Choose between Stress Relax, Flow, Creep, etc 
ii. Edit procedure as desired 
b. To select a saved procedure: Procedure  Saved  (pick file) 
14) Put on goggles and one glove (left = gloved, right = computer hand) 
a. COMPUTER IS GLOVE FREE ZONE 
15) REMEMBER, NEVER PUT HAND BETWEEN PLATE AND 
GEOMETRY; ALWAYS USE TWEEZERS OR SPATULA TO MOVE 
SAMPLES 
16) Place hydrogel on center of peltier plate using spatula or inject 0.07ml to the 
center. 
17) Lower geometry within 3 mm of sample 
18) If everything is ready to go, then select Experiment  Run 
a. Name the experiment file with description, initials, and date  
b. Select where the file should be saved 
19) If asked to ‘Set Gap’, go to Instrument  Set gap 
a. Gap = sample height 
20) Run your experiment, wait for it to conclude.  
21) Export the data and save it. 
22) Raise and clean geometry and plate with DI water. Wipe dry. 
23) Reload next sample and go back to step 17.  
24) Shut down following protocol. 
25) Mineral Oil  
a. Transfer into 1ml  
i. Centrifuge 1 min 3000rpms  
b. Run N=5 for each group  
i. Viscosity Test 25°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 25°C 
ii. Viscosity Test 37°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 37°C 
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26) Mineral Oil Span 80 
a. Transfer into 1ml  
i. Centrifuge 1 min 3000rpms  
b. Run N=5 for each group  
i. Viscosity Test 25°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 25°C 
ii. Viscosity Test 37°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 37°C 
27) 2% Alg solutions in DI/PBS/Media  
a. For 4mL of testing solution  
i. 4mL of solvent  in 10mL syringe  
ii. 0.08 grams of alginate material  
iii. Centrifuge 1 min at 3000rpms   
b. Transfer into 1ml  
i. Centrifuge 1 min 3000rpms  
c. Run N=5 for each group  
i. Viscosity Test 25°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 25°C 
ii. Viscosity Test 37°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 37°C 
iii. Oscillary calcium chloride Time Sweep  
1. Procedure newoscillationmiddle bullet on left 
menuchange to time sweep    
2. Duration: 10 mins 
3. Deformed 1% strain  
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4. 10 Hz 
5. Delay time 10s 
6. Performed at 37°C 
iv. Oscillary Temperature Sweep  
1. Procedure newoscillationmiddle bullet on left 
menuchange to temp 
2. 1 Hz 
3. 1% strain  
4. Heating rate 0.5°C min-1  
5. Performed at 25-37°C 
6. 15 sec equilibrium time 
 
28) 2% Alg-MA solutions in DI/PBS/Media  
a. For 4mL of testing solution  
i. 4mL of solvent in 10mL syringe  
ii. 0.08 grams of alginate material  
iii. Centrifuge 1 min at 3000rpms   
b. Transfer into 1ml  
i. Centrifuge 1 min 3000rpms  
c. Run N=5 for each group  
i. Viscosity Test 25°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 25°C 
ii. Viscosity Test 37°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 37°C 
iii. Oscillary Calcium chloride Time Sweep  
1. Duration: 10 mins 
2. Deformed 1% strain  
3. 10 Hz 
4. Performed at 37°C 
iv. Oscillary Temperature Sweep  
1. 1 Hz 
2. 1% strain  
3. Heating rate 0.5°C min-1  
  
73 
 
4. Performed at 25-37°C 
29) 2% Alg-MA-β-CD solutions in DI/PBS/Media  
a. For 4mL of testing solution  
i. 4mL of solvent in 10mL syringe  
ii. 0.08 grams of alginate material  
iii. Centrifuge 1 min at 3000rpms   
b. Transfer into 1ml  
i. Centrifuge 1 min 3000rpms  
c. Run N=5 for each group  
i. Viscosity Test 25°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 25°C 
ii. Viscosity Test 37°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 37°C 
iii. Oscillary calcium chloride Time Sweep  
1. Duration: 10 mins 
2. Deformed 1% strain  
3. 10 Hz 
4. Performed at 37°C 
iv. Oscillary Temperature Sweep  
1. 1 Hz 
2. 1% strain  
3. Heating rate 0.5°C min-1  
4. Performed at 25-37°C 
 
30) Repeat steps 25-27 and add a 1:1 F108 ratio into syringe with alginate 
material  
a. For 4mL of testing solution  
i. 4mL of solvent in 10mL syringe  
ii. 0.08 grams of alginate material  
iii. 0.08 grams of F108  
 
31) For Green Light Testing  
a. For 4mL of testing solution  
  
74 
 
i. 4mL of solvent 
ii. 0.08 grams of alginate material  
iii. 0.08 grams of F108  
b. Make 4 groups:  Alg, Alg-MA, and Alg-MA-β-CD 
c. Prepare stock crosslinking solutions (Nettles, Vail, Morgan, & 
Grinstaff, 2004): 
i. 4 mL methacrylated polymer solution in PBS water (6% 
solution). 
ii.  0.5% eosin Y (photosensitizer, EY) in 1-vinyl-2-pyrrolidinone 
(catalyst, 1VP) 
iii. 5M triethanolamine (initiator, TEOA) in DI water. 
d. Add 100 µL of the TEOA solution to the polymer solution and mix 
thoroughly 
e. Add 10 µL of the EY/1VP solution to the 2 mL polymer solution and 
mix. 
f. Expose mold to visible green light of wavelength 510 nm for 2-6 
minutes to crosslink hydrogel(Bahney, Lujan, & Hsu, 2011). 
g. Run N=5 for each group  
i. Oscillary Time Sweep (while green light is on) 
1. Duration: 10 mins 
2. Deformed 1% strain  
3. 10 Hz 
4. Performed at 37°C 
ii. Viscosity Test 25°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 25°C 
iii. Viscosity Test 37°C 
1. Procedure  Flow procedure (continuous ramp) 
2. Shear rate (1/s) 0.1 to 100.0 
3. Duration 2:00 mins  
4. Sampling points 120 
5. Performed at 37°C 
iv. Oscillary calcium chloride Time Sweep  
1. Duration: 10 mins 
2. Deformed 1% strain  
3. 10 Hz 
4. Performed at 37°C 
v. Oscillary Temperature Sweep   
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1. 1 Hz 
2. 1% strain  
3. Heating rate 0.5°C min-1  
4. Performed at 25-37°C 
Rheometer Shut-Down 
1. Close software. 
2. Switch off the power supply switch. 
3. Remove geometry by screwing spindle to the left; make sure to support the 
geometry as it is loosened – do NOT drop it! 
4. Replace black cap and tighten with spindle (to the right). 
5. Close the valve handle attached to the filter on the wall so that it is perpendicular 
to tubing. 
6. Close the valve handle and re-secure the metal lock on the main regulator for the 
in-house compressed air.  
7. Wipe down Peltier plate and geometry using deionized water or 70% ethanol and 
a Kim wipe.   
 
 
 
 
 Standard Operating Procedure: MFDs-Cell-Encapsulation-Alg-MA-β-CD-
GreenLight  
MATERIALS:  
• Human mesenchymal stem cells (hMSC)  
• MEM No Phenol Red  
• MSC-screened FBS  
 
Groups:  
A. Cells encapsulated in 2% Alg-MA-β-CD 
B. Cells in 2% Alg-MA-β-CD (left out of incubator same time length) 
C. Cells suspended in media (left out of incubator same time length)  
METHODS: 
Cell Culture:  
Standard Growth Medium 
MEM No Phenol Red  
10% (v/v) MSC FBS  
1% (v/v) Antibiotic-Antimycotic  
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NO SERUM Standard Growth Medium 
MEM No Phenol Red  
1% (v/v) Antibiotic-Antimycotic  
 
Frozen Cell Recovery 
1) Pre-warm growth medium in 37°C water bath. 
2) Take cells out of liquid nitrogen tank and immediately thaw in 37°C water 
bath. 
a. Check all containers for leakage or breakage. 
b. Do not submerge the vial completely. When the vial is 95% thawed 
remove it from the bath. (2-3 mins)  
3) Using a micropipette, gently add the thawed cell suspension to 6 mL of basic 
growth medium in a 15mL tube. 
4) Centrifuge at 200 x g for 10 min 
5) Aspirate media 
6) Re-suspend cells with growth medium and place in cell culture flask. 
a. Recommended seeding density if 5,000-6,000 cells per cm2; about 
375,000 – 500,000 cells per T75 flask. 
b. Add the appropriate amount of medium to the vessels (0.2-0.4 mL per 
cm2); about 10-12 mL per T75 flask. 
c. Gently rock flask back and forth to evenly distribute cells and 
carefully place in incubator at 37°C and 5% CO2.  
7) Next day, change fresh growth medium. 
8) Change medium every 3~4 days until 70~90% confluency. 
  
Subculturing to 25 million cells  
1) The cells were sub-cultured at a ratio of 1:3 using the following procedure 
2) Media was aspirated off and the cell layer  
3) 4 mL of 0.25% (w/v) Trypsin- 0.53mM EDTA solution was added  
4) The flask was incubated for 8 minutes at 37.0°C and 5.0% (v/v) CO2  
5) 4 mL of cell media was added  
6) Cell solution was added to 50mL test tube  
7) Centrifuge at 600rpm for 10 min. 
8) Solution is aspirated to leave just the cell pellet 
9) Cell pellet was re-suspended to create 10 million cells/ml  
 
 
Microsphere Fabrication: 
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32) Prepare stock crosslinking solutions (Nettles, Vail, Morgan, & Grinstaff, 
2004): 
a. Create 0.5% eosin Y (photosensitizer, EY) in 1-vinyl-2-pyrrolidinone 
(catalyst, 1VP) solution 
b. Create 5M triethanolamine (initiator, TEOA) in DI water solution 
c. Filter each solution through a fresh 0.2µm syringe filter  
33) For 1 mL of Alg-MA-β-CD testing solution 
a. Put 0.8 mL of NO SERUM cell media in a 10mL syringe  
i. Ensure the media used has no serum                                                                                                             
b. Add 0.02 grams of alginate material  
c. Mix solution until all alginate is dissolved and centrifuge out all air 
d. Centrifuge a 3000rpm for 1 minute  
e. Turn off lights and preform under red light  
i. From here on all operations must be in the dark unless 
materials with photo-initiator are covered with aluminum foil 
f. Add 50 µL of the TEOA solution to the polymer solution and mix 
thoroughly 
g. Add 5 µL of the EY/1VP solution to the 1 mL polymer solution and 
mix 
h. Add 200 µL of a 10million/ml solution 
i. To create 2million/ml cells in 1ml of 2% Alg-MA-β-CD 
i. Centrifuge 1 min at 1000rpms   
j. Transfer into 1ml syringe 
i. Centrifuge 1 min 1000rpms  
ii. This should help to remove air, but not settle cells 
34) Group C  
a. Add media to remaining stock of cells to create a 5 million/ml solution  
b. Leave in suspension at room temperature for duration of cell 
encapsulation procedure   
35) The 1ml syringe is lure locked to a female pink 20 gage end needle and locked 
into a syringe pump 
a. Install Telfon tube from needle to MFD dispersion flow inlet 
i. Syringe pump will pump at 0.0004 ml/min 
b. The continuous fluid in a 10ml syringe is installed with the same 
components into its inlet 
i. Syringe pump will pump at 0.008ml/min  
36) As the pumps run, observe the MFD junction with an inverted microscope.  
37) Collect output in a 3ml centrifuge tube 
i. This tube can contain different solutions based on the 
crosslinking method 
ii. If just using green light, add 1.5ml of cell media 
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iii. If using calcium chloride, add a concentration with cell media 
b. The tube is places in a hole in a carboard box 
c. Inside the box is an array of green LED lights, which are on 
d. The box protects the alginate in the device from crosslinking 
38) Every hour switch out collection centrifuge tubes 
a. Shake and centrifuge for 1 minute at 1000rpm 
b. Aspirate off oil layer and most of the other solutions leaving a 
microsphere pellet 
c. Suspend pellet in 200µl of cell media 
 
Live/Dead Staining:   
1) Live/Dead Assay  
a. “Thaw Component A and Component B vials  
i. These tasks are still preformed in red light 
b. Add 1 µL calcein AM (Component A) and 1mL ethidium homodimer-1 
(Component B)  
c. Remove media from cells 
d. Add 100-200 µL if staining solution to encapsulated cells  
e. Wait 15 minutes   
2) Image using fluoresce cell counter  
 
 
 
 Abstracts 
 Manufactured Alginate Drug Delivery Vehicles for Disease Prevention and Tissue 
Regeneration 
Microfluidics is an expanding field due to precise control capabilities afforded by using 
small controlled portions of material. Microfluidics flow focusing devices (MFFD) allow 
for multiple experiments to be performed on small scales with accurate metering 
capability. Soft lithography manufacturing methods can be used to create MFFDs that are 
biocompatible. Additionally, amongst the many fluids that flow though the micro 
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channels of these devices, alginate solutions can be monodispersed into a continuous 
flow by controlling flow rate and orifice diameter within the channel.  The mechanism of 
dispersion comes from capillary pressure and shear forces brought on by the impinging 
continuous flow fluid at a junction of two or more channels.  The dispersion fluid 
cyclically breaks off and surface tension forces the fluid to form a microsphere. If the 
flow rates, fluid viscosities, and channel features remain the same, the microspheres’ 
physical properties will not vary and are thus homogeneous in size and shape. The 
microspheres that are created with other techniques, such as mixing emulsions on stir 
plates, are not homogenous in size. There exist methods to filter the mixed solutions of 
spheres, resulting in wasted material and time.  Ideally there is a way to create 
microspheres at the required size, which may be possible with the use of a MFFD. The 
University of Vermont’s Engineering Biomaterials Research Laboratory has investigated 
alginate microspheres (AMs) as a tool to deliver pharmaceuticals for the treatment of 
various cancers and diseases, in particular, osteoporosis.  Osteoporosis is a disease 
resulting in decreased bone mass density and fragile weakened bones. Long durations of 
spaceflight result in musculoskeletal disuse and may result in osteoporosis.  Using AMs 
that are small enough to pass through cell membranes, proteins and pharmaceuticals can 
be delivered intracellularly. The EBRL is interested in AMs that are large enough to 
encapsulate entire cells, even stem cells, for use as injectable scaffolds to regrow tissues 
such as, bone damaged by injury or disease progression. Each use requires microspheres 
in different distinct size ranges. In addition to the inconsistent sizes created, the current 
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MFFD design causes the microchannels to become obstructed after a minimal number of 
uses, rendering the device ineffective. Thus, we propose to design second generation 
MFFDs to manufacture monodisperse AMs with controllable dimension for various 
applications.  
The perfection of the MFFDs will directly lead to advancements in drug delivery and 
osteogenic regeneration (Joshi et al. 2011). Certain microsphere formulations can 
transport bioactive vascular endothelial growth factor A (VEGFA) into primary human 
mesenchymal stem cells and significantly enhance osteogenic differentiation. This has 
NASA interest because these microspheres can be used in a therapy to treat spaceflight 
osteopenia.  A more widespread public application could include the treatment of 
osteoporosis. AMs have protein permeable membranes, which makes them ideal for 
transporting VEGFA (figure 1). The problem is the microsphere size influences the 
encapsulation efficiency. AMs have also been shown to be biocompatible with living 
cells and can be made small enough to travel intracellularly.  For all these uses, having 
microspheres of a homogeneous hydraulic diameter is critical and can offer distinct 
advantages for cell study. The best way to create the prescribed microspheres is with a 
microfluidic flow focusing device. Controlling the microsphere hydraulic diameter will 
make these ongoing experiments using AMs more replicable. 
 
  
81 
 
 
 Society of Biomaterials Spring 2017: Manufacturing Methacrylated Sodium 
Alginate Beta-Cyclodextrin Microspheres for Drug Delivery 
Statement of Purpose: Microfluidics is an expanding field due to precise control 
capabilities afforded by using small controlled portions of material. Microfluidics flow 
focusing devices (MFFD) allow for multiple experiments to be performed on small scales 
with accurate metering capability. Soft lithography manufacturing methods can be used 
to create MFFDs that are biocompatible. Additionally, amongst the many fluids that 
flows though the micro channels of these devices, alginate solutions can be 
monodispersed into a continuous flow by controlling flow rates and orifice diameter 
within the channel.  The mechanism of dispersion comes from capillary pressure and 
shear forces brought on by the impinging continuous flow fluid at a junction of two or 
more channels.  The dispersion fluid cyclically breaks off and surface tension forces the 
fluid to form a microsphere. If the flow rates, fluid viscosities, and channel features 
remain the same, the microspheres’ physical properties will not vary and are thus 
homogeneous in size and shape.  The University of Vermont’s Engineering Biomaterials 
Research Laboratory has investigated alginate microspheres (AMs) as a tool to deliver 
pharmaceuticals for the treatment of various cancers and diseases. Using AMs that are 
small enough to pass through cell membranes, ions, proteins, and pharmaceuticals can be 
delivered intracellularly. Methacrylated sodium alginate beta-cyclodextrin (Alg-MA-β-
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CD) is biocompatible supramolecular material suited for drug delivery due to the guest-
host interaction properties of cyclodextrin complexes where hydrophobic interactions 
happen inside central molecular cavities binding guest molecules with van der Waals 
forces, electrostatic interactions, and or hydrogen bonding.      
 
 Rheological Data 
 
Figure 27: Mineral Oil Viscosity Test at 25°C 
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Figure 28: Mineral Oil Viscosity Test at 37°C 
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Figure 29: Comparison of Average of Mineral Oil at 25°C and 37°C 
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Figure 30: Mineral Oil with 2% Span80 Viscosity at 25°C 
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Figure 31: Mineral Oil with 2% Span80 Viscosity at 37°C 
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Figure 32: Mineral Oil with 2% Span80 Average Viscosities at 25°C and 37°C 
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Figure 33: 2% Alg Viscosity at 25°C 
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Figure 34: 2% Alg Viscosity at 37°C 
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Figure 35: 2% Alg Average Viscosities at 25°C and 37°C 
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Figure 36: 2% Alg-MA Viscosity at 25°C 
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Figure 37: 2% Alg-MA Viscosity at 37°C 
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Figure 38: 2% Alg-MA Average Viscosities at 25°C and 37°C 
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Figure 39: 2% Alg-MA-β-CD Viscosity at 25°C 
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Figure 40: 2% Alg-MA-β-CD Viscosity at 37°C 
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Figure 41: 2% Alg-MA-β-CD Average Viscosities at 25°C and 37°C 
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Figure 42: 2% Alg and 2% F108 Viscosity at 25°C 
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Figure 43: 2% Alg and 2% F108 Viscosity at 37°C 
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Figure 44: 2% Alg and 2% F108 Averages Viscosity at 25°C 37°C 
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Figure 45: 2% Alg-MA and 2% F108 Viscosity at 25°C 
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Figure 46: 2% Alg-MA and 2% F108 Viscosity at 37°C 
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Figure 47 : 2% Alg-MA and 2% F108 Average Viscosities at 25°C and 37°C 
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Figure 48: 2% Alg-MA-β-CD and 2% F108 Viscosity at 25°C 
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Figure 49: 2% Alg-MA-β-CD and 2% F108 Viscosity at 37°C 
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Figure 50: 2% Alg-MA-β-CD  and 2% F108 Average Viscosities at 25°C and 37°C 
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Figure 51: 2% Alg Time Sweep with 1M calcium chloride Added at 1 Minute 
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Figure 52: 2% Alg-MA Time Sweep with 1M calcium chloride Added at 1 Minute 
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Figure 53: 2% Alg-MA-β-CD  Time Sweep with 1M calcium chloride Added at 1 
Minute 
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Figure 54: 2% Alg-MA-β-CD  and 2% F108 Time Sweep with 1M calcium chloride 
Added at 1 Minute 
 
